Melphalan for Injection 50 mg (Melphalan (Melphalan Hydrochloride) KIT) 50 MG

Melphalan for Injection 50 mg is a chemotherapy medication used to treat certain types of cancer. This kit contains Melphalan Hydrochloride, a potent antineoplastic agent, for intra-arterial administration.

Strength

50 MG

Manufacturer / TM Owner

MARCAN PHARMACEUTICALS INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Melphalan for Injection 50 mg is primarily used in the treatment of various cancers, including multiple myeloma and ovarian cancer. It works by interfering with the growth of cancer cells, making it a crucial component in chemotherapy regimens. Patients often wonder, 'What is Melphalan used for?' and the answer lies in its ability to target and destroy rapidly dividing cells.

Side Effects

Common effects of Melphalan for Injection 50 mg may include nausea, vomiting, and bone marrow suppression. These effects can vary among individuals and are typically managed under medical supervision. Patients should be aware of potential side effects and discuss them with their healthcare provider.

Precautions & Warnings

Handling Melphalan for Injection 50 mg requires careful precautions due to its potent nature. It should be administered by healthcare professionals in a controlled environment. Patients should follow their healthcare provider's instructions regarding storage and administration to ensure safety.

Avoid Interactions

Melphalan for Injection 50 mg may interact with other medications, including certain antibiotics and immunosuppressants. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances may also affect the efficacy and safety of Melphalan.

Frequently Asked Questions

Melphalan is used in the treatment of certain types of cancer, such as multiple myeloma and ovarian cancer.

Melphalan for Injection 50 mg is typically administered intra-arterially by healthcare professionals.

Common side effects may include nausea, vomiting, and bone marrow suppression.

Melphalan may interact with other medications, so it is important to consult a healthcare provider before combining treatments.

Melphalan should be handled with care and administered by healthcare professionals in a controlled environment.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.